March 2012 Br J Cardiol 2012;19:24 doi:10.5837/bjc.2012.003
Rachael Boggon, Susan Eaton, Adam Timmis, Harry Hemingway, Zahava Gabriel, Iqbal Minhas, Tjeerd P van Staa
Abstract
Introduction
Cardiovascular disease (CVD) is the leading cause of death in England and Wales (124,000 deaths in 2005) and for every fatality, there are at least two people who have a major non-fatal CVD event.1 Myocardial infarction (MI) is associated with substantial morbidity and mortality. There is a high risk of recurrence after the initial event. Recommendations on the secondary prevention of cardiovascular disease for patients in primary and secondary care have been published in guidelines from the National Institute for Health and Clinical Excellence (NICE) in England.1,2 In the May 2008 CG67 guideline, high-intensity dosage of statin
|
Full text
